Because IL-2 secreted during acute P. chabaudi malaria might influence the late phase of the immune response either directly or through its effects on Treg cells, we evaluated the effects of JES6-1 treatment on the CD4+ T cell phenotype and proliferative response on days 20 and 30 p.i., respectively. The gene discussed is CD4; the disease is malaria.